SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-21-200532
Filing Date
2021-06-25
Accepted
2021-06-25 17:01:02
Documents
2
Group Members
JOSEPH EDELMANPERCEPTIVE LIFE SCIENCES MASTER FUND, LTD.PERCEPTIVE XONTOGENY VENTURE FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d105323dsc13da.htm SC 13D/A 89750
2 EX-1 d105323dex991.htm EX-99.1 6313
  Complete submission text file 0001193125-21-200532.txt   97692
Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 646-205-5300
PERCEPTIVE ADVISORS LLC (Filed by) CIK: 0001224962 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
CATABASIS PHARMACEUTICALS INC (Subject) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88910 | Film No.: 211048802
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences